GPC3 and hepatocellular carcinoma: Shimizu et al. demonstrated that plasma GPC-3 levels and tumoral expression are significantly higher in patients with HCV-related HCC compared to those with hepatitis B virus-related or non-viral HCC, indicating that viral background may modulate GPC-3 regulation [27].